Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases

Springer, CNS Drugs, 1(37), p. 45-67, 2022

Journal article published in 2022 by Jessica A. Wilcox

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by